SKI Market

Indian Indices

Nifty

25,461.00 55.70
(0.22%)

Sensex

83,432.89 193.42
( 0.23%)

Bank Nifty

57,031.90 239.95
( 0.42%)

Nifty IT

39,166.55 312.25
( 0.80%)

Global Indices

Nasdaq

44,849.54 344.11
(0.77%)

Dow Jones

6,300.35 51.93
(0.83%)

Hang Seng

39,792.23 6.33
(0.02%)

Nikkei 225

8,822.91 -0.29
(0.00%)

Forex

USD-INR

85.44 -0.20
(-0.23%)

EUR-INR

100.61 -0.32
(-0.32%)

GBP-INR

116.59 -0.52
(-0.45%)

JPY-INR

0.59 0.00
(-0.64%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Lal Pathlabs Ltd

Industry : Healthcare

BSE Code

ISIN Demat

Book Value()

539524

INE600L01024

254.778098

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LALPATHLAB

47.85

23871.41

EPS(TTM)

Face Value()

Div & Yield %

59.55

0.84

Back

Shukra Pharmaceuticals standalone net profit rises 35.09% in the March 2025 quarter

May 30,2025

Net profit of Shukra Pharmaceuticals rose 35.09% to Rs 5.39 crore in the quarter ended March 2025 as against Rs 3.99 crore during the previous quarter ended March 2024. Sales rose 21.97% to Rs 13.27 crore in the quarter ended March 2025 as against Rs 10.88 crore during the previous quarter ended March 2024.

For the full year,net profit declined 48.33% to Rs 9.58 crore in the year ended March 2025 as against Rs 18.54 crore during the previous year ended March 2024. Sales declined 56.30% to Rs 32.59 crore in the year ended March 2025 as against Rs 74.57 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	13.27	10.88	22	32.59	74.57	-56
OPM %	55.09	40.81	-	39.03	26.02	-
PBDT	8.51	5.75	48	16.34	21.93	-25
PBT	7.57	5.23	45	13.34	19.88	-33
NP	5.39	3.99	35	9.58	18.54	-48

25,461.00 55.70 (0.22%)

83,432.89 193.42 ( 0.23%)

57,031.90 239.95 ( 0.42%)

39,166.55 312.25 ( 0.80%)

44,849.54 344.11 (0.77%)

6,300.35 51.93 (0.83%)

39,792.23 6.33 (0.02%)

8,822.91 -0.29 (0.00%)

85.44 -0.20 (-0.23%)

100.61 -0.32 (-0.32%)

116.59 -0.52 (-0.45%)

0.59 0.00 (-0.64%)